Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Adams

Vascular Surgery Ogden, UT Medical Doctor

NPI 1144492943 CMS profile 1347160

3903 Harrison Blvd, Suite 100, Ogden, UT 84403

Open in the dashboard

General payments

$14,134

139 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brian Adams of Ogden, UT is reported in the CMS Open Payments database as having received $14,134 across 139 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $567 11
2024 General $4,132 33
2023 General $3,214 27
2022 General $1,456 18
2021 General $680 10
2020 General $1,443 11
2019 General $2,642 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Adams
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Brian Adams were reported at $567. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Brian Adams Vascular Surgery median Middle half National median
2019 $2,642 $796 $226–$2,363 $163
2020 $1,443 $348 $118–$1,110 $114
2021 $680 $471 $158–$1,421 $132
2022 $1,456 $725 $222–$2,183 $149
2023 $3,214 $836 $257–$2,440 $160
2024 $4,132 $909 $252–$2,619 $164
2025 $567 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $3,111 20 payments
  2. W. L. Gore & Associates, Inc. $3,018 33 payments
  3. Silk Road Medical, Inc. $2,289 22 payments
  4. Inari Medical, Inc. $2,263 7 payments
  5. Centinel Spine, LLC $1,172 3 payments
  6. Bolton Medical Inc $742 15 payments
  7. Medtronic, Inc. $247 4 payments
  8. Cook Medical LLC $221 7 payments
  9. Shockwave Medical, Inc $219 4 payments
  10. Boston Scientific Corporation $216 7 payments
  11. Other $636 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,320 119 payments
  2. Travel and Lodging $6,814 20 payments
Products named General payments · program years 2019–2025
  1. Indigo System $2,573 12 payments
  2. CT THROMBECTOMY SYSTEM KIT $2,263 7 payments
  3. FLOWTRIEVER CATHETER, S $2,263 7 payments
  4. TAG Thoracic Endoprosthesis $1,418 7 payments
  5. ENROUTE Transcarotid Stent $1,378 16 payments
  6. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $1,378 16 payments
  7. PRODISC L $1,172 3 payments
  8. ENROUTE 0.014 Guidewire $910 6 payments
  9. ENROUTE Transcarotid Stent System $910 6 payments
  10. ENROUTE Transcarotid Neuroprotection System Carotid Artery Disease $910 6 payments
  11. Other $6,688 105 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 104 billing codes

Paid by Medicare

$102,959

Medicare's payments for the services billed

Medicare patients

422

Average age 75

Services billed

830

186 women, 236 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 50%
Chronic kidney disease 45%
Ischemic heart disease 44%
Diabetes 41%
Heart failure 29%
Atrial fibrillation 27%
Depression 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $26
$26 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

139 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record